AI assistant
Sending…
Climb Bio, Inc. — Director's Dealing 2024
Jul 12, 2024
33982_dirs_2024-07-11_e31d6758-8263-406f-a46d-f49dcd954364.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Eliem Therapeutics, Inc. (ELYM)
CIK: 0001768446
Period of Report: 2024-07-09
Reporting Person: Morisset Valerie (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-09 | Common Stock | S | 5931 | $6.66 | Disposed | 444683 | Direct |
| 2024-07-10 | Common Stock | S | 50000 | $6.83 | Disposed | 394683 | Direct |
| 2024-07-11 | Common Stock | S | 50000 | $7.11 | Disposed | 344683 | Direct |
More from Climb Bio, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Director's Dealing
2026
Feb 27
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Jan 8